Public company research profile

This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.

Open in CopyWindow

Company research history

West Pharmaceutical Services, Inc. Common Stock (WST)

Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.

9 disclosures
3 insiders
0 cluster signals
0.0% avg. 30d outcome

Company facts

Ticker / ISIN
WST / Not available
Exchange
Not available
Country
US
Sector
Not available

Disclosure history

Lisa McClain, Representative

sell disclosed on 13 Aug 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Lisa McClain, Representative

buy disclosed on 13 Aug 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Rob Bresnahan, Representative

sell disclosed on 8 May 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Rob Bresnahan, Representative

buy disclosed on 27 Mar 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Jared Moskowitz, Representative

sell disclosed on 6 Mar 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Jared Moskowitz, Representative

sell disclosed on 9 Dec 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Jared Moskowitz, Representative

buy disclosed on 21 Aug 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Jared Moskowitz, Representative

buy disclosed on 21 Aug 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Jared Moskowitz, Representative

buy disclosed on 22 Jan 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%